Egido E - Search Results

1

Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations.

Egido E, Müller R, Li-Blatter X, Merino G, Seelig A. Egido E, et al. Mol Pharm. 2015 Nov 2;12(11):4026-37. doi: 10.1021/acs.molpharmaceut.5b00463. Epub 2015 Sep 30. Mol Pharm. 2015. PMID: 26372856

2

Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1).

Xu Y, Egido E, Li-Blatter X, Müller R, Merino G, Bernèche S, Seelig A. Xu Y, et al. Among authors: egido e. Biochemistry. 2015 Oct 13;54(40):6195-206. doi: 10.1021/acs.biochem.5b00649. Epub 2015 Sep 29. Biochemistry. 2015. PMID: 26381710

3

The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP.

Barrera B, Otero JA, Egido E, Prieto JG, Seelig A, Álvarez AI, Merino G. Barrera B, et al. Among authors: egido e. Antimicrob Agents Chemother. 2012 Jul;56(7):3535-43. doi: 10.1128/AAC.06345-11. Epub 2012 Apr 16. Antimicrob Agents Chemother. 2012. PMID: 22508302 Free PMC article.

4

Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin.

Real R, Egido E, Pérez M, González-Lobato L, Barrera B, Prieto JG, Alvarez AI, Merino G. Real R, et al. Among authors: egido e. J Vet Pharmacol Ther. 2011 Aug;34(4):313-21. doi: 10.1111/j.1365-2885.2010.01241.x. Epub 2010 Oct 11. J Vet Pharmacol Ther. 2011. PMID: 20950350

5

In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.

Merino G, Perez M, Real R, Egido E, Prieto JG, Alvarez AI. Merino G, et al. Among authors: egido e. Pharm Res. 2010 Oct;27(10):2098-105. doi: 10.1007/s11095-010-0208-5. Epub 2010 Jul 7. Pharm Res. 2010. PMID: 20607366

6

Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas.

Silvestre RA, Egido EM, Hernández R, Marco J. Silvestre RA, et al. Among authors: egido em. Regul Pept. 2009 Feb 25;153(1-3):37-42. doi: 10.1016/j.regpep.2008.11.008. Epub 2008 Dec 7. Regul Pept. 2009. PMID: 19101596

7

Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas.

Egido EM, Hernández R, Marco J, Silvestre RA. Egido EM, et al. Regul Pept. 2009 Jan 8;152(1-3):61-6. doi: 10.1016/j.regpep.2008.08.003. Epub 2008 Aug 19. Regul Pept. 2009. PMID: 18773927

8

Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas.

Silvestre RA, Egido EM, Hernández R, Marco J. Silvestre RA, et al. Among authors: egido em. J Endocrinol. 2008 Feb;196(2):283-90. doi: 10.1677/JOE-07-0454. J Endocrinol. 2008. PMID: 18252951

9

Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas.

Marco J, Egido EM, Hernández R, Silvestre RA. Marco J, et al. Among authors: egido em. Peptides. 2008 May;29(5):852-8. doi: 10.1016/j.peptides.2007.08.025. Epub 2007 Sep 4. Peptides. 2008. PMID: 17931748

10

26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas.

Egido EM, Hernández R, Leprince J, Chartrel N, Vaudry H, Marco J, Silvestre RA. Egido EM, et al. Peptides. 2007 Apr;28(4):725-30. doi: 10.1016/j.peptides.2006.04.004. Epub 2006 Jun 13. Peptides. 2007. PMID: 16777265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters